RKDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arcadia Biosciences Inc (RKDA) is not a good buy at the moment for a beginner investor with a long-term strategy. The company is experiencing declining financial performance, no recent positive news or catalysts, and lacks clear bullish technical indicators. Additionally, there are no strong trading signals or influential trades to suggest immediate upside potential.
The MACD is slightly positive and expanding, but RSI is neutral at 41.433. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The stock is trading below the pivot level of 1.365, with key support at 1.303 and resistance at 1.426.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Declining financial performance in Q4 2025, with revenue down -25.90% YoY, net income down -67.13% YoY, and EPS down -67.45% YoY. Gross margin also dropped significantly by -33.39%.
In Q4 2025, revenue dropped to $901,000 (-25.90% YoY), net income fell to -$1,336,000 (-67.13% YoY), EPS dropped to -0.97 (-67.45% YoY), and gross margin declined to 21.31% (-33.39% YoY).
No analyst rating or price target data available.
